Cancellation of state registration. Estarizol

December 9, 2016
Active substances:
Trade names:
ICD-10:
II.C50    Malignant neoplasm of breast)
II.C50.C50    Malignant neoplasm of breast
Anastrozole, Estarizole, breast cancer, breast tumor, treatment of breast cancer

The Ministry of Health of the Russian Federation in accordance with Article 32 of the Federal Law of 12.04.2010 No. 61-FZ "On the circulation of medicinal products" decided to abolish state registration and exclusion from the state register of medicines formedical application of the medicinal product (registration certificate LP-000138 dated January 12, 2011 issued by Actavis PTS ef., Iceland):

Estarizol (trade name of the medicinal product)

Anastrozole (international non-proprietary, or grouping, or chemical name medicinal product)

tablets, film-coated, 1 mg (dosage form, dosage)

Sinton Spain, SL, Spain Pol. Ind. Les Salines. Carrer Castello, 1, 08830 Sant Boi de llobregat (Barcelona), Spain (name and address of the location of the manufacturer of the medicinal product)

on the basis of filing by the authorized legal entity LLC "Aktavis", Russia of a request for the cancellation of the state registration of a medicinal product.